Regulation of L-type calcium channel by intracellular subunit in cardiac hypertrophy and failure.
Project/Area Number |
23390212
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Circulatory organs internal medicine
|
Research Institution | Osaka University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
ASAHI Michio 大阪医科大学, 薬理学, 教授 (10397614)
FUJIO Yasushi 大阪大学, 薬学研究科, 教授 (20359839)
|
Project Period (FY) |
2011-04-01 – 2014-03-31
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥19,370,000 (Direct Cost: ¥14,900,000、Indirect Cost: ¥4,470,000)
Fiscal Year 2013: ¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2012: ¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2011: ¥10,530,000 (Direct Cost: ¥8,100,000、Indirect Cost: ¥2,430,000)
|
Keywords | カルシウム / チャネル / 心肥大 / 心不全 / カルモデュリン依存性キナーゼ / マイクロドメイン / シグナリング / カルシウムチャネル / プロテインキナーゼA / 細胞死 |
Research Abstract |
L-type calcium channel (LTCC) localizes at T-tubules and caveolae in cardiomyocytes, and plays major roles in excitation-contraction coupling and cardiac hypertrophy. The expression of b2a subunit of LTCC (b2a) is increased in human failing heart. Phosphorylation of b2a by CaMKII enhanced LTCC activity. In the present study, we examined the pathological role of b2a phosphorylation in cardiac hypertrophy. We developed a method to examine caveolae-specific activation of CaMKII and found that b2a phosphorylation occurs specifically in caveolae and elicit myocyte hypertrophy in a1 adrenergic stimulation. Thus, we generated transgenic mice (TG) overexpressing non phosphorylated mutant of b2a.The expressions of b2a in both mutant and wild-type TG were similar. a1 adrenergic stimulation induced cardiac hypertrophy was attenuated in mutant TG compared to wild-type TG mice. In conclusion, we revealed that phosphorylated b2a localized at caveolae and exaggerates cardiac hypertrophy.
|
Report
(4 results)
Research Products
(30 results)
-
[Journal Article] Toll-like receptor 9 protects non-immune cells from stress by modulating mitochondrial ATP synthesis through the inhibition of SERCA22014
Author(s)
Shintani Y, Drexler HC, Kioka H, Terracciano CM, Coppen SR, Imamura H, Akao M, Nakai J, Wheeler AP, Higo S, Nakayama H, 他3名
-
Journal Title
EMBO Rep
Volume: 15(4)
Pages: 438-45
Related Report
-
-
[Journal Article] Genetic modulation of the SERCA activity does not affect the Ca2+ leak from the cardiac sarcoplasmic reticulum.2014
Author(s)
Morimoto S, Hongo K, Kusakari Y, Komukai K, Kawai M, O-Uchi J, Nakayama H, Asahi M, Otsu K, Yoshimura M, Kurihara S.
-
Journal Title
Cell Calcium.
Volume: 55
Issue: 1
Pages: 17-23
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Toll-like receptor 9 protects non-immune cells from stress by modulating mitochondrial ATP synthesis through the inhibition of SERCA2.2014
Author(s)
Shintani Y, Drexler HC, Kioka H, Terracciano CM, Coppen SR, Imamura H, Akao M, Nakai J, Wheeler AP, Higo S, Nakayama H, Takashima S, Yashiro K, Suzuki K.
-
Journal Title
EMBO Reports
Volume: 15
Issue: 4
Pages: 438-445
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
[Journal Article] Cathelicidin antimicrobial peptide inhibits fibroblast migration via P2X7 receptor signaling.2013
Author(s)
Kumagai, S., Matsui, K., Kawaguchi, H., Yamashita, T., Mohri, T., Fujio, Y., Nakayama, H.
-
Journal Title
Biochem. Biophys. Res. Commun.
Volume: 437
Issue: 4
Pages: 609-614
DOI
Related Report
Peer Reviewed
-
[Journal Article] Autophagy-mediated degradation is necessary for regression of cardiac hypertrophy during ventricular unloading.2013
Author(s)
Oyabu J, Yamaguchi O, Hikoso S, Takeda T, Oka T, Murakawa T, Yasui H, Ueda H, Nakayama H, Taneike M, Omiya S, Shah AM, Nishida K, Otsu K.
-
Journal Title
Biochemical and Biophysical Research Communication
Volume: 441
Issue: 4
Pages: 787-792
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-